)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
SCYNEXIS
SCYNEXIS (SCYX) investor relations material
SCYNEXIS Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary10 Aug, 2026
Executive summary
Acquired SCY-770, a novel AMPK activator for ADPKD, with Orphan Drug Designation; Phase 1 initiated with topline data expected Q3 2026 and Phase 2 planned for Q4 2026–2027.
Proprietary antifungal platform includes SCY-247 (Phase 1 completed, topline data Q3 2026) and BREXAFEMME, licensed to GSK, with milestone and royalty potential.
Completed a $40M private placement in March 2026, strengthening liquidity and supporting pipeline advancement.
Ended Q2 2026 with $71.1M in cash, cash equivalents, and investments, supporting operations into 2029.
Financial highlights
License agreement revenue was $0.2M for Q2 2026, down from $1.4M in Q2 2025.
Net income for Q2 2026 was $7.4M, compared to a net loss of $6.9M in Q2 2025, driven by a $14.2M gain from warrant liability fair value adjustment.
R&D expenses for Q2 2026 were $3.9M, down 46% from $7.1M in Q2 2025; SG&A expenses increased 9% to $4.1M.
Cash, cash equivalents, and investments totaled $71.1M as of June 30, 2026, up from $56.3M at year-end 2025.
Outlook and guidance
Topline data from Phase 1 SCY-770 and SCY-247 studies expected in Q3 2026; Phase 2 SCY-770 to begin Q4 2026, with early efficacy data in H2 2027.
Cash runway projected to last into 2029.
Potential to receive up to $146M in milestones and royalties from BREXAFEMME relaunch by GSK.
Additional capital may be needed for future operations, potentially through equity, debt, or partnerships.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from SCYNEXIS
- All six proxy proposals were approved with no shareholder questions submitted.SCYX
AGM 2026 - Shareholders approved a reverse stock split and reduction of authorized shares.SCYXEGM 2026
- Q1 2026 featured a major acquisition, $21.3M net loss, and cash runway extended to mid-2029.SCYXQ1 2026
- Resale registration for 87M shares from a private placement; proceeds only from warrant exercises.SCYXRegistration filing
- Key votes include board elections, auditor ratification, and major share authorization changes.SCYXProxy filing
- Annual meeting seeks approval for director elections, equity plan expansion, and capital increase.SCYXProxy filing
- Shareholders will vote on a reverse stock split to help maintain Nasdaq listing compliance.SCYXProxy filing
- Shareholders will vote on director elections, compensation, equity plan, and capital structure changes.SCYXProxy filing
- Shareholders will vote on a reverse stock split to help maintain Nasdaq listing compliance.SCYXProxy filing
Next SCYNEXIS earnings date
Q3 202611 Nov, 2026
SCYNEXIS
Next SCYNEXIS earnings date
Q3 202611 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage